Speakers
Beth Arnold, Partner, Foley Hoag LLP
Steven Barrett, Partner, Co-Chair, Technology Transactions and Licensing Practice Group, WilmerHale
Daniel Behr, Senior Vice President, Access BridgeGap Ventures
Christine Bellon, Vice President, Legal Affairs, Blueprint Medicines
Nicholas M. Boivin, Director, Intellectual Property Counsel, Cubist Pharmaceuticals, Inc.
Hemmie Chang, Chair Licensing & Strategic Alliances Group, Partner, Life Sciences Group, Foley Hoag LLP
Carl Charneski, Counsel, Brinks Hofer Gilson & Lione
Mary Beth Cicero, Principal, DrugMarketInfo
Hal Craig, Principal, Trout Creek Consulting, LLC
Jeff Elton, Managing Director, Accenture
Douglas Fambrough, CEO, Dicerna Pharmaceuticals
Tom Filarski, Partner, Steptoe & Johnson
Patrick Gattari, Partner, McDonnell Boehnen Hulbert & Berghoff LLP
Krish Gupta, Senior Vice President & Deputy General Counsel, EMC Corp.
Pavan Handa, Senior Vice President, Business Development, Antares Pharma, Inc.
Kim Houston, Executive Director, everythingHEALTH, LLC
Skip Irving, Partner and Managing Director, Health Advances
Ariel D. Jasie, Senior Director, Business Development, Celgene Corporation
Linda Johnson, National Director Strategic Alliances, Juvenile Diabetes Research Foundation
Elaine Jones, Executive Director, Venture Capital, Worldwide Business Development, Pfizer
Myron Kassaraba , Partner, Pluritas, LLC
Sandhya Kilaru, Wiggin and Dana LLP
Robert S. Langer, David H. Koch Institute Professor, MIT
Susan Levy, Principal, Susan B. Levy Consulting
Ellen Locker, Executive Director, Alliance Management, Merck
Heather Lounsbury, Sr. Director, Portfolio Management & Business Planning, Avila Therapeutics
Janet MacLeod, Partner, Fox Rothschild LLP
Nagesh Mahanthappa, VP Corporate Development & Operations, Avila Therapeutics
Robert Mallin, Shareholder, Brinks Hofer Gilson & Lione
John McDonald, Co-Head Business Development and Mergers & Acquisitions, Biogen Idec
David Meeker, President & CEO, Genzyme
Patricia Melick, Partner, Wiggin and Dana LLP
Mark Nawacki, VP Business & Corporate Development, Paladin Labs Inc.
Robert Nissen, Head, Nissen Consulting Group, LLC
Christopher Noble, Technology Licensing Officer, Massachusetts Institute of Technology
Kevin Noonan, Partner, McDonnel Boehnen Hulbert & Berghoff
Gerard Norton, Partner, Fox Rothschild LLP
Rekha Paleyanda, Sr. Business Strategy & Licensing Manager, Massachusetts General Hospital
Anish Patel, PharmD, Associate Director, CTI Strategy & Operations, Centers for Therapeutic Innovation (CTI)
Branko Pejic, Partner, Greenblum & Bernstein
Jill Pierard, Director, Intellectual Property, Sigma-Aldrich
Ruth Plager, President, ZenithBIO
Michal Preminger, Executive Director of Office of Technology Development, Harvard Medical School Office
Jason Rhodes, Executive Vice President and Chief Business Officer, Epizyme, Inc.
Jeffrey Rothstein, Partner, Sidley Austin
Charles Ryan, Sr. V.P. and Chief I.P. Counsel, Forest Laboratories
James Sailer, Vice President, Corporate Affairs, Population Council
Michael Samardzija, PhD, CLP, Partner, Bracewell & Giuliani LLP
Stefani Shek, Industrial Contracts Associate, Stanford University
Ednaldo Silva, Managing Partner, RoyaltyStat
Robin Sitver, Executive Director, Business Development, Johnson & Johnson Healthcare Products
Cathy Sohn, President, Sohn Health Strategies
Kevin Spivak, Of Counsel, Greenblum & Bernstein
Lesley Stolz, VP Business Development, Sutro Biopharma
Frances Toneguzzo, Executive Director of Research Ventures & Licensing, Partners Research Ventures and Licensing
Lyle Vander Schaaf, Managing Partner, Brinks Hofer Gilson & Lione
Robin Walker, Associate GC, Biogen Idec
Annette Weissbach, Global Alliance Director, Pharma Partnering, Hoffmann-La Roche Inc.
Teri Willey, Vice President for Technology and Business Development, Mount Sinai School of Medicine
Scott Williams, Director, Invotex Group
Joe Wyse, President, Wyse Innovations
George Young, Business & Financial Manager, Population Council
Ken Zinda, President, Inspherion
Daphne Zohar, Founder, Managing Partner, Puretech Ventures